Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis

Walter P Maksymowych*, Howard H Z Thom, Michael Morup, Vanessa Taieb, Damon Willems, Nikos Lyris, Karl Gaffney

*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science